These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 11402945)

  • 21. [Sudden cardiac death : Epidemiology, pathophysiology and risk stratification].
    Rudic B; Tülümen E; Liebe V; Kuschyk J; Akin I; Borggrefe M
    Herz; 2017 Apr; 42(2):123-131. PubMed ID: 28229201
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical course and prognostic relevance of antitachycardia pacing-terminated ventricular tachyarrhythmias in implantable cardioverter-defibrillator patients.
    Kleemann T; Strauss M; Kouraki K; Zahn R
    Europace; 2015 Jul; 17(7):1068-75. PubMed ID: 25687746
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sudden cardiac death: who needs an implantable cardioverter-defibrillator and who needs antiarrhythmic drugs?
    Ferrari R; Cinca J; Marber M
    Eur Heart J; 1999 Mar; 20(6):397-8. PubMed ID: 10213339
    [No Abstract]   [Full Text] [Related]  

  • 24. A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators.
    Buxton AE; Lee KL; Fisher JD; Josephson ME; Prystowsky EN; Hafley G
    N Engl J Med; 1999 Dec; 341(25):1882-90. PubMed ID: 10601507
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevention of sudden cardiac death with implantable cardioverter-defibrillators in children and adolescents with hypertrophic cardiomyopathy.
    Maron BJ; Spirito P; Ackerman MJ; Casey SA; Semsarian C; Estes NA; Shannon KM; Ashley EA; Day SM; Pacileo G; Formisano F; Devoto E; Anastasakis A; Bos JM; Woo A; Autore C; Pass RH; Boriani G; Garberich RF; Almquist AK; Russell MW; Boni L; Berger S; Maron MS; Link MS
    J Am Coll Cardiol; 2013 Apr; 61(14):1527-35. PubMed ID: 23500286
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Survival and appropriate device interventions in recipients of cardioverter defibrillators implanted for the primary versus secondary prevention of sudden cardiac death.
    Stockburger M; Krebs A; Nitardy A; Habedank D; Celebi O; Knaus T; Dietz R
    Pacing Clin Electrophysiol; 2009 Mar; 32 Suppl 1():S16-20. PubMed ID: 19250084
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Updated ESC guideline: innovations for the treatment of ventricular arrhythmias and recommendations for prevention of sudden cardiac death].
    Eckardt L; Deneke T
    Herzschrittmacherther Elektrophysiol; 2016 Sep; 27(3):288-94. PubMed ID: 27581243
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Implantable cardioverter-defibrillator: present and future indications.
    Block M; Scheld H; Breithardt G
    Arch Mal Coeur Vaiss; 1996 Feb; 89 Spec No 1():141-7. PubMed ID: 8734176
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and safety of celivarone, with amiodarone as calibrator, in patients with an implantable cardioverter-defibrillator for prevention of implantable cardioverter-defibrillator interventions or death: the ALPHEE study.
    Kowey PR; Crijns HJ; Aliot EM; Capucci A; Kulakowski P; Radzik D; Roy D; Connolly SJ; Hohnloser SH;
    Circulation; 2011 Dec; 124(24):2649-60. PubMed ID: 22082672
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Factors predisposing to ventricular tachyarrhythmia leading to appropriate ICD intervention in patients with coronary artery disease or non-ischaemic dilated cardiomyopathy.
    Lelakowski J; Piekarz J; Rydlewska A; Majewski J; Senderek T; Ząbek A; Małecka B
    Kardiol Pol; 2012; 70(12):1264-75. PubMed ID: 23264245
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of age on survival and causes of death after primary prevention implantable cardioverter-defibrillator implantation.
    Fauchier L; Marijon E; Defaye P; Piot O; Sadoul N; Perier MC; Gras D; Klug D; Algalarrondo V; Bordachar P; Deharo JC; Leclercq C; Babuty D; Boveda S;
    Am J Cardiol; 2015 May; 115(10):1415-22. PubMed ID: 25784518
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical trials update: sudden cardiac death prevention by implantable device therapy.
    Finch NJ; Leman RB
    Crit Care Nurs Clin North Am; 2005 Mar; 17(1):33-8, x. PubMed ID: 15749399
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ventricular arrhythmias. Preventing sudden death with drugs and ICD devices.
    Doherty JU; Fuchs S; Tecce MA
    Geriatrics; 2000 Aug; 55(8):26-8, 31-2, 35-6. PubMed ID: 10953684
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The automatic implantable cardioverter-defibrillator for prevention of sudden heart death in children and adolescents].
    Paul T; Luhmer I; Trappe HJ; Klein H; Fieguth HG; Brauer C; Scharpwinkel U; Kallfelz HC
    Z Kardiol; 1993 Aug; 82(8):466-73. PubMed ID: 8212779
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The contradiction of appropriate shocks in primary prevention ICDs: increasing and decreasing the risk of death.
    Sweeney MO
    Circulation; 2010 Dec; 122(25):2638-41. PubMed ID: 21135359
    [No Abstract]   [Full Text] [Related]  

  • 36. Re: Predictors of all-cause mortality for patients with chronic Chagas' heart disease receiving implantable cardioverter defibrillator therapy.
    Cardinalli-Neto A; Bestetti RB; Cordeiro JA
    J Cardiovasc Electrophysiol; 2008 Apr; 19(4):E34-5. PubMed ID: 18298517
    [No Abstract]   [Full Text] [Related]  

  • 37. Coronary artery reperfusion for ST elevation myocardial infarction is associated with shorter cycle length ventricular tachycardia and fewer spontaneous arrhythmias.
    Nalliah CJ; Zaman S; Narayan A; Sullivan J; Kovoor P
    Europace; 2014 Jul; 16(7):1053-60. PubMed ID: 24158256
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictors of death and occurrence of appropriate implantable defibrillator therapies in patients with ischemic cardiomyopathy.
    Ng AC; Bertini M; Borleffs CJ; Delgado V; Boersma E; Piers SR; Thijssen J; Nucifora G; Shanks M; Ewe SH; Biffi M; van de Veire NR; Leung DY; Schalij MJ; Bax JJ
    Am J Cardiol; 2010 Dec; 106(11):1566-73. PubMed ID: 21094356
    [TBL] [Abstract][Full Text] [Related]  

  • 39. What can we expect from prophylactic implantable defibrillators?
    Wilber DJ; Kall JG; Kopp DE
    Am J Cardiol; 1997 Sep; 80(5B):20F-27F. PubMed ID: 9291446
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nonsustained ventricular tachycardia and other high-risk predictors following myocardial infarction: implications for prophylactic automatic implantable cardioverter-defibrillator use.
    Wilber DJ; Kopp D; Olshansky B; Kall JG; Kinder C
    Prog Cardiovasc Dis; 1993; 36(3):179-94. PubMed ID: 8234772
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.